3-year Disease-free Survival
1 clinical trials · Condition
◉ Watch 3-year Disease-free Survival
| Record | Firm | Date |
|---|---|---|
| Befotertinib Adjuvant Therapy in Stage IA2-IB NSCLC Patients (NCT06561620) | Fudan University | 2024-05-01 |
Track 3-year Disease-free Survival automatically
Every clearance here is in the API, with alerts when new ones post.